secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2021-10-01T23:59:59+00:00
Accession:  0001493152-21-024390
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hancock Jaffe Laboratories renamed enVVeno Medical; new tickers NVNO and NVNOW
------------------------------------------------------------------------------

- Name change effective 12:01 a.m. Eastern on October 1, 2021.
- Certificate of Amendment filed with Delaware Secretary of State on September 29, 2021.
- Common stock now trades as NVNO; warrants as NVNOW on Nasdaq.
- Company had previously been known as Hancock Jaffe Laboratories, Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315221024390/0001493152-21-024390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315221024390/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-024390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer